Search

ASTRAZENECA SPINOUT ENTASIS FILES FOR $86M IPO TO FUND ANTIBIOTIC PHASE 3

Entasis Therapeutics has filed to raise up to $86 million through an IPO. The AstraZeneca spinout is seeking the money to fund a phase...

Subject CAR-Ts to price competition or randomized trials to ensure even coverage, expert says

SUBJECT CAR-TS TO PRICE COMPETITION OR RANDOMIZED TRIALS TO ENSURE EVEN COVERAGE, EXPERT SAYS

CMS could run trials of CAR-Ts in lymphoma if unsure of their similarity on benefit to patients and ancillary service costs, Dr. Peter...

 
 
 
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More

BIO ROUNDUP: BIG APPROVALS, ICER INFLUENCE, DRUG-PRICE PUSHBACK & MORE

We'll start the roundup this week with two drug approvals that came late last Friday. Both were landmarks for the companies receiving...

STRUCTURAL TARGET CONTROLLABILITY OF LINEAR NETWORKS

Computational analysis of the structure of intra-cellular molecular interaction networks can suggest novel therapeutic approaches for...

 
 
 

COMBINED CERIUM OXIDE NANOCAPPING AND LAYER-BY-LAYER COATING OF POROUS SILICON CONTAINERS FOR CONTROLLED DRUG RELEASE

Abstract Local drug release in close vicinity of solid tumors is a promising therapeutic approach in cancer therapy. Implantable drug...

Digital Tools, Online Community & More: Patient Partnership Award Finalists

DIGITAL TOOLS, ONLINE COMMUNITY & MORE: PATIENT PARTNERSHIP AWARD FINALISTS

Patients are supposed to be at the center of medicine, but the sheer size and complexity of the healthcare and life science industries...

 
 
 

RESEARCH TECHNICIAN AT A STARTUP

Delve Therapeutics is seeking highly motivated applicants for a part-time position as a research technician in a laboratory developing...

 
 
 

RESEARCH TECHNICIAN IN STARTUP

Delve Therapeutics is seeking highly motivated applicants for a part-time position as a research technician in a laboratory developing...

Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More

BIO ROUNDUP: MEDICARE DRUG PRICES, FDA MOVES, GENE THERAPY NEWS & MORE

Two imminent FDA rulings on two separate drugs aren't just noteworthy for the patients they'll help, but the long and winding road...

 
 
 
 
 
 
 
 
 

OVID POSTS RESULTS FROM MIDSTAGE RARE DISEASE TEST, PLOTS REGISTRATIONAL PATH

Ovid Therapeutics has posted a batch of topline data out of its midstage STARS trial in Angelman syndrome as it seeks out a path to...

 
 
 

CHEMISTRY INTERN

Conju-Probe is a chemistry technology company committed to developing a broad range of cutting-edge tools and provide custom design...

Bio Roundup: Alnylam's Moment, Read on Rebates, Skinny Plans & More

BIO ROUNDUP: ALNYLAM'S MOMENT, READ ON REBATES, SKINNY PLANS & MORE

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren't taking a break from the gamesmanship...

 
 
 
Ketamine as Potential Agent for Teenagers with Treatment-Resistant Depression

KETAMINE AS POTENTIAL AGENT FOR TEENAGERS WITH TREATMENT-RESISTANT DEPRESSION

Intravenously injected ketamine has positive therapeutic effects among adolescents with treatment-resistant depression .

Video game fan Elon Musk wants to put video games in every Tesla, and he's asking game designers to apply

VIDEO GAME FAN ELON MUSK WANTS TO PUT VIDEO GAMES IN EVERY TESLA, AND HE'S ASKING GAME DESIGNERS TO APPLY

Reuters Soldier 76 main and Tesla CEO Elon Musk is looking to hire game developers at Tesla to create games. The games are intended...